Decision Diagnostics' Board Votes to Uplist to OTC QX

Decision Diagnostics' Board Votes to Uplist to OTC QX 
Company Engages Sponsoring Brokerage and Designated Advisor for
Disclosure, and Plans Immediate Application to OTC QX, the Premier
OTC Market Tier 
LOS ANGELES, CA -- (Marketwired) -- 12/10/13 --  Decision Diagnostics
Corp. (OTCBB: DECN), the exclusive worldwide sales, service and
regulatory processes agent for the popular Shasta GenStrip(TM), the
unique Green Glucose Test Strip, specifically designed to work with
the Johnson & Johnson's (NYSE: JNJ) LifeScan Ultra family of glucose
testing meters, today announced that the company's Board of Directors
has approved the company's uplisting to the OTC QX, the Premier OTC
Market Tier. Concurrent with these Board Resolutions, the company has
engaged a sponsoring brokerage and engaged counsel who shall serve as
the company's Designated Advisor for Disclosure (DAD). 
Keith Berman, Principal Executive Officer of Decision Diagnostics,
commented, "The uplisting to the OTC QX is an activity we have
considered for some time. Our ultimate goal is to achieve a listing
on NYSE MKT (formerly NYSE Amex). However, the current uplist to the
premier OTC market tier will accomplish the much needed goals of
allowing our stock to be quoted and traded by a wider range of
brokerages, particularly retail brokers, without many of the issues
we endure as a fully reporting OTC BB company. We will have more to
discuss about other aspects of this uplist registration in the coming
days." 
Interested parties may view the OTC QX web site:  
http://www.otcqx.com/qx/otcqx/requirements 
Forward-Looking Statements: 
This release contains forward-looking statements about our business
or financial condition that reflect our assumptions and beliefs based
on information currently available. We can give no assurance that the
expectations indicated by such forward-looking statements will be
realized. There may be other risks and circumstances that we are
unable to predict. When used in this release, words such as
"believes," "expects," "forecasts," "intends," "projects," "plans,"
"anticipates," "estimates," "will" and similar expressions are
intended to identify forward-looking statements, although there may
be certain statements not accompanied by such expressions.  
For further information about Shasta GenStrip, please visit the
company's Web Sites: http://www.decisiondiagnostics.com/ or
http://www.shastagenstrip.com/. The company also reminds all
interested parties that the airing of its commercial video titled
"GenStrip: A Patchwork of Life began on November 1 and will continue.
We are currently filming additional Patchwork of Life commercials.
And in the meantime the extremely popular video is available for
viewing at: http://shastagenstrip.com/shasta_ad.html or
http://youtu.be/zzBuHxb-rlM.  
GenStrip(TM) test strips are a product of Shasta Technologies, LLC
and are not manufactured, distributed, endorsed, or approved by nor
associated with LifeScan(R), Inc. a Johnson & Johnson(R) Company,
manufacturers and distributors of the OneTouch(R) Ultra(R) Family of
Meters and OneTouch(R) Ultra(R) test strips purchased prior to July
2013.  
Decision Diagnostics Corp.
Keith Berman
(805) 446-2973
info@decisiondiagnostics.com
 
 
Press spacebar to pause and continue. Press esc to stop.